Free Trial

iSpecimen Q2 2023 Earnings Report

iSpecimen logo
$3.00 +0.04 (+1.35%)
(As of 12/20/2024 05:45 PM ET)

iSpecimen EPS Results

Actual EPS
-$0.39
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

iSpecimen Revenue Results

Actual Revenue
$1.63 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

iSpecimen Announcement Details

Quarter
Q2 2023
Time
N/A

Conference Call Resources

70%, 80%, 90% Win Rates? Grab Your Free Cheatsheets Today! (Ad)

Would you like to know the historic win rate of every trade you take before you place it? Well, it’s all possible with these FIVE Candlestick Pattern Cheatsheets.

>> You can grab your FREE, laminated copies right here << 

iSpecimen Earnings Headlines

This Indicator called BOTH NVDA rallies
Rarely would I label something as “the best” But in this rare instance, I believe this is THE BEST indicator for trading Nvida’s stock. Except, it’s not another tech stock like Nvidia. But rather a stock hiding in broad daylight… So, if you’d like to see what this stock is…
iSpecimen Appoints Robert Lim as New CEO
iSpecimen Inc. Reports Earnings Amid Financial Challenges
iSpecimen Reports Third Quarter 2024 Results
See More iSpecimen Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like iSpecimen? Sign up for Earnings360's daily newsletter to receive timely earnings updates on iSpecimen and other key companies, straight to your email.

About iSpecimen

iSpecimen (NASDAQ:ISPC) provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, clinics, private practice groups, laboratories, blood centers, biobanks, clinical research sites, and cadaveric donation centers. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. iSpecimen Inc. was incorporated in 2009 and is headquartered in Lexington, Massachusetts.

View iSpecimen Profile

More Earnings Resources from MarketBeat

Upcoming Earnings